Parkinsons disease DBS
Deep Brain Stimulation (DBS) is used for severe Parkinson's motor symptoms. It's safe and reversible, targeting brain regions with implanted electrodes. Risks include infection and hardware issues. Long-term benefits include improved rigidity, tremor, and motor fluctuations, but bradykinesia improvement may decline.
Parkinsons disease Apomorphine usage
Apomorphine is a potent dopamine agonist used for sudden "off" periods in Parkinson's disease. It can be administered subcutaneously or sublingually. Subcutaneous injection requires premedication, close monitoring, and ECG. Sublingual absorption bypasses metabolism but may cause side effects. Continuous subcutaneous infusion (CSAI) is an option with potential side effects, including skin nodules and hematological issues. Regular monitoring is necessary for safety.
Parkinsons disease Gel Infusion protocol
Levodopa-carbidopa intestinal gel (LCIG) is used for Parkinson's disease to reduce motor fluctuations. It's delivered via a tube with a battery-powered pump. Vitamin B12 levels should be monitored, and patients may need additional oral levodopa at night if "wearing off" occurs. Precautions include potential adverse events and tube maintenance.
Parkinsons disease Freezing episodes
Freezing of gait in Parkinson's disease can be managed by adjusting levodopa doses during "off" periods and using non-pharmacological strategies like physical therapy. Medications like methylphenidate and amantadine may help. Investigational therapies like dopaminergic cell transplantation show promise.
Parkinsons disease Falls
Falls in Parkinson's disease can be prevented through regular assessment and risk evaluation. Tools like the POMA score assess balance and gait. Treating freezing of gait and postural hypotension is crucial. Deep brain stimulation may help in advanced cases.
Parkinsons disease Sleep disorders
Sleep disorders in Parkinson's disease, including insomnia and excessive daytime sleepiness, can impact patients' quality of life. Management involves education, light therapy, exercise, and medication adjustments. Restless leg syndrome may require lifestyle changes and medication.
Parkinsons disease GI disorders
Gastrointestinal issues are common in Parkinson's disease, including nausea, vomiting, dysphagia, reflux, and constipation. Managing these symptoms involves various approaches, including medication adjustments, dietary modifications, and rehabilitation therapy to improve the patient's quality of life. Sialorrhea and drooling are also prevalent and can be addressed through appropriate measures.
Parkinsons disease Dysautonomia
Autonomic neuropathy in Parkinson's disease can manifest with symptoms like constipation, postural hypotension, rhinorrhea, sexual dysfunction, and sialorrhea. Management includes various strategies and medications to address these issues, with a focus on improving the patient's quality of life.
Parkinsons disease Psychiatric issues
Psychiatric and behavioral disorders in Parkinson's disease may include visual hallucinations, delusions, and depression. Managing psychosis involves identifying underlying causes, adjusting antiparkinson medications, and considering antipsychotic agents like quetiapine, clozapine, or pimavanserin. These drugs have specific dosing considerations and potential side effects.
Parkinson disease Cognitive impairment
Cognitive impairment in Parkinson's disease can manifest as executive dysfunction, visuospatial difficulties, or memory deficits. Treatment options include cholinesterase inhibitors (e.g., rivastigmine, donepezil) and memantine. Cholinesterase inhibitors may have mild benefits but can cause side effects, while memantine's effectiveness needs further confirmation.
Parkinsons disease Akinetic attacks
Acute akinesia is a sudden worsening of Parkinson's disease characterized by immobility lasting several days. It often responds poorly to standard Parkinson's medications and can be lethal. It's important to identify and address underlying causes, such as infection or medication errors, in hospitalized patients.
Parkinsons disease Diphasic Dyskinesia
Diphasic dyskinesia, characterized by two peaks of dyskinesia after levodopa doses, can be challenging to manage. Strategies include adjusting levodopa dosing, adding dopamine agonists, and considering infusion therapies or surgeries if other options fail.
Parkinsons disease Wearing off Phenomena
Long-term levodopa use in Parkinson's disease can result in "wearing off" motor fluctuations. Strategies include dietary changes, dose adjustments, long-acting formulations, and adjunctive therapies like dopamine agonists, MAOB inhibitors, COMT inhibitors, and istradefylline. Rescue options are also available.
Parkinsons disease Peak dose Dyskinesia
Dyskinesia, often due to excessive dopamine stimulation, occurs after levodopa intake. Treatment options include adjusting levodopa dosing, using amantadine, or considering adjunctive therapies like low-dose clozapine. Some patients prefer living with dyskinesia.
Parkinsons disease Recurrent Off periods
Effective treatments for reducing "off" periods in Parkinson's disease include carbidopa/levodopa enteral suspension (Duopa), levodopa inhalation powder, sublingual apomorphine film, and add-on medications like safinamide and istradefylline, all of which have demonstrated significant improvements in managing off-periods.
Parkinsons disease Basic Management
Parkinson's disease treatment involves non-pharmacological approaches like exercise, occupational therapy, and nutrition. Tai chi and yoga have shown benefits. Pharmacological options include levodopa, dopamine agonists, MAOB inhibitors, amantadine, and anticholinergic drugs, each with considerations. Surgery may be considered for certain cases, such as DBS.